2
Clinical Trials associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)An International, Multi-centric, Comparative, Randomized, Parallel group, double-blind, placebo-controlled, phase III clinical trial study to evaluate safety and efficacy of the drug products ReliBeta (Reliance Life Sciences Pvt. Ltd.â??, India) versus Avonex (Biogen Idec Limited, Great Britain) in the treatment of patients with remitting multiple sclerosis and open after-treatment with Interferon β1а - REAV
Start Date15 Sep 2015 |
Sponsor / Collaborator- |
Prospective, multicentre, open label, clinical study to evaluate efficacy and safety of R-TPR-011 in patients with multiple sclerosis.
100 Clinical Results associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
100 Translational Medicine associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
100 Patents (Medical) associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
100 Deals associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)